文献速递产科母胎医学

妊娠期与产后罕见血栓性微血管病的鉴别与管理

Differentiating and Managing Rare Thrombotic Microangiopathies During Pregnancy and Postpartum.
PubMed 文献 · Obstet Gynecol · 2022-12-02

妊娠期最常见血栓性微血管病(TMA)为子痫前期伴HELLP综合征,但血栓性血小板减少性紫癜、补体介导溶血性尿毒症综合征及灾难性抗磷脂综合征等罕见TMA也可于妊娠或产后发生,表现与重度子痫前期相似。本文基于现有客观信息和工作组推荐,提供诊断与管理这些罕见TMA的实用临床方法,并讨论有罕见TMA病史者备孕时的管理。

要点

  • 妊娠期最常见TMA为子痫前期伴HELLP综合征,罕见TMA表现可与重度子痫前期重叠。
  • 早期识别和治疗罕见TMA是避免严重母体并发症及母胎死亡的关键。
  • 优化结局需产科、母胎医学、血液科和肾内科等多学科协作并密切临床与实验室监测。

核心结论

  • 早期识别和治疗妊娠期或产后罕见TMA对避免严重母体并发症、长期后遗症及母胎死亡至关重要。
  • 由于罕见TMA发病率低,缺乏高质量的妊娠期诊断与管理循证推荐,本报告基于现有客观信息和工作组推荐提供实用临床方法。

研究设计与样本

  • 本报告基于当前客观信息和工作组推荐,提供妊娠期与产后罕见TMA诊断与管理的实用临床方法。
  • 报告同时讨论有罕见TMA病史者备孕时的管理。

主要发现

  • 妊娠期最常见的TMA为子痫前期伴HELLP综合征。
  • 罕见TMA包括血栓性血小板减少性紫癜、补体介导溶血性尿毒症综合征和灾难性抗磷脂综合征,可于妊娠或产后发生。
  • 罕见TMA与重度子痫前期在临床和实验室表现上存在显著重叠,鉴别诊断具有挑战性。

关键数值与推荐

  • 原文未报告具体诊断阈值或推荐等级。

临床怎么用

  • 优化结局需产科、母胎医学、血液科和肾内科等多学科协作,并密切临床与实验室监测。
  • 对有罕见TMA病史且计划妊娠者,应进行管理咨询。

局限性

  • 由于这些TMA罕见,缺乏高质量的妊娠期诊断与管理循证推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The most common thrombotic microangiopathy (TMA) of pregnancy is the well-recognized syndrome of preeclampsia with hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome. However, rare TMAs, including thrombotic thrombocytopenic purpura, complement-mediated hemolytic-uremic syndrome, and catastrophic antiphospholipid syndrome, may occur during pregnancy or postpartum and present with features similar to those of preeclampsia with severe features. Early recognition and treatment of these infrequently encountered conditions are key for avoiding serious maternal morbidities with long-term sequelae and possible maternal or fetal death. Differentiating between preeclampsia with severe features and these rare TMAs is diagnostically challenging as there is significant overlap in their clinical and laboratory presentation. Given the rarity of these TMAs, high-quality evidence-based recommendations on diagnosis and management during pregnancy are lacking. Using current objective information and recommendations from working groups, this report provides practical clinical approaches to diagnose and manage these rare TMAs. This report also discusses how to manage individuals with a history of these rare TMAs who are planning to conceive. To optimize favorable outcomes, a multidisciplinary approach including obstetricians, maternal-fetal medicine specialists, hematologists, and nephrologists alongside close clinical and laboratory monitoring is vital.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Lim MY, Abou-Ismail MY, Branch DW, et al. Differentiating and Managing Rare Thrombotic Microangiopathies During Pregnancy and Postpartum. Obstet Gynecol. 2022. PMID: 36455925. doi:10.1097/AOG.0000000000005024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。